Literature DB >> 18181007

Outcome of duodenal switch with a transitory vertical gastroplasty, in super-super-obese patients in an 8-year series.

Ernesto Di Betta1, Francesco Mittempergher, Riccardo Nascimbeni, Bruno Salerni.   

Abstract

BACKGROUND: In super-super obese (SSO) patients [body mass index (BMI) superior of 60 kg/m2] results of bariatric surgery are still controversial. This study evaluated safety and efficacy of open duodenal switch associated with transitory vertical gastroplasty (DS-TVG) after 8 years of follow-up.
METHODS: A prospective observational study of 32 SSO patients who underwent an open DS-TVG from January 1999 till March 2006 was performed. Study endpoints included preoperative comorbidities [diabetes, hypertension, and obstructive sleep apnea syndrome (OSAS)], postoperative morbidity and mortality, and long-term results of BMI and percent of excess weight loss (%EWL) (median 48 months).
RESULTS: Results in terms of BMI and %EWL were, respectively, after 12 months, 46.3 +/- 10.2 and 57.1 +/- 9.8; after 36 months (n = 21), 37.5 +/- 7.5 and 73.5 +/- 6.2; and after 84 months (n = 5), 31.7 +/- 2.8 and 76.0 +/- 4.1. With regard to comorbidities, we observed complete control of lipid alterations and type-2 diabetes (suspension therapy within 1 year). All patients with OSAS improved within 1 year without needing domiciliary oxygen therapy. Neither malnutrition nor mortality was observed during the follow-up. Major complications occurred in a total of 5 patients (15.6%): pulmonary embolism (2 cases-9.4%); gastrointestinal bleeding, requiring transfusions (1 case-3.1%); 1 case (3.1%) of abdominal rupture; and 1 case of acute pancreatitis (3.1%). Minor complications occurred in 4 patients (12.5%): 1 case of pneumonia, 1 urinary tract infection, and 2 wound infections.
CONCLUSION: Although this study evaluated the outcomes of a small series of patients after open DS-TVG, this procedure seems to be safe and effective in obese patients who have a BMI greater than 60 kg/m2. In our opinion, DS-TVG should be considered as a valid surgical option with two staged laparoscopic procedures.

Entities:  

Mesh:

Year:  2008        PMID: 18181007     DOI: 10.1007/s11695-007-9293-x

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  21 in total

1.  Short-term results of laparoscopic gastric bypass in patients with BMI > or = 60.

Authors:  David Oliak; Garth H Ballantyne; Richard J Davies; Annette Wasielewski; Hans J Schmidt
Journal:  Obes Surg       Date:  2002-10       Impact factor: 4.129

2.  Gastric cancer after Roux-en-Y gastric bypass.

Authors:  Alex Escalona; Sergio Guzmán; Luis Ibáñez; Luis Meneses; Alvaro Huete; Antonieta Solar
Journal:  Obes Surg       Date:  2005-03       Impact factor: 4.129

Review 3.  The biliopancreatic diversion with the duodenal switch: results beyond 10 years.

Authors:  Douglas S Hess; Douglas W Hess; Richard S Oakley
Journal:  Obes Surg       Date:  2005-03       Impact factor: 4.129

4.  Gastric bypass for severe obesity: approaches and outcomes.

Authors:  Philip Schauer
Journal:  Surg Obes Relat Dis       Date:  2005 May-Jun       Impact factor: 4.734

5.  Postoperative complications are not increased in super-super obese patients who undergo laparoscopic Roux-en-Y gastric bypass.

Authors:  D S Tichansky; E J DeMaria; A Z Fernandez; J M Kellum; L G Wolfe; J G Meador; H J Sugerman
Journal:  Surg Endosc       Date:  2005-05-05       Impact factor: 4.584

6.  Biliopancreatic diversion with transitory gastroplasty preserving duodenal bulb: 3 years experience.

Authors:  C Vassallo; L Negri; A Della Valle; M Salvaneschi; C Vegezzi; A Griziotti; C Dono; P Mussi; M G Bausardo; P Pietrobono
Journal:  Obes Surg       Date:  1997-02       Impact factor: 4.129

Review 7.  Obesity: surgical options.

Authors:  Karl Miller
Journal:  Best Pract Res Clin Gastroenterol       Date:  2004-12       Impact factor: 3.043

8.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

9.  Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.

Authors:  Francesco Rubino; Jacques Marescaux
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

10.  Gastric cancer after gastric bypass for obesity. Case report.

Authors:  I Raijman; S V Strother; W L Donegan
Journal:  J Clin Gastroenterol       Date:  1991-04       Impact factor: 3.062

View more
  3 in total

1.  Long-term results of biliopancreatic diversion with or without gastric preservation for morbid obesity.

Authors:  Nicola Crea; Giacomo Pata; Ernesto Di Betta; Francesco Greco; Claudio Casella; Antonio Vilardi; Francesco Mittempergher
Journal:  Obes Surg       Date:  2011-02       Impact factor: 4.129

2.  High incidence of appendix carcinoid tumors among candidates for bariatric surgery: diagnostic and therapeutic implications.

Authors:  Nicola Crea; Giacomo Pata; Ernesto Di Betta; Amin Titi; Francesco Mittempergher
Journal:  Obes Surg       Date:  2011-02       Impact factor: 4.129

3.  Preoperative prediction of growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis modification and postoperative changes in candidates for bariatric surgery.

Authors:  Francesco Mittempergher; Giacomo Pata; Nicola Crea; Ernesto Di Betta; Antonio Vilardi; Deborah Chiesa; Riccardo Nascimbeni
Journal:  Obes Surg       Date:  2013-05       Impact factor: 4.129

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.